Pseudolaric acid B suppresses NSCLC progression through the ROS/AMPK/mTOR/autophagy signalling pathway
Open Access
- 25 April 2024
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 175, 116614
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Mechanisms of cancer cell death induction by paclitaxel: an updated reviewApoptosis, 2022
- Dendrobium officinale polysaccharide triggers mitochondrial disorder to induce colon cancer cell death via ROS-AMPK-autophagy pathwayCarbohydrate Polymers, 2021
- Morusin induces apoptosis and autophagy via JNK, ERK and PI3K/Akt signaling in human lung carcinoma cellsChemico-Biological Interactions, 2020
- ROS-dependent signal transductionCurrent Opinion in Cell Biology, 2015
- The Immunosuppressive Activity of Pseudolaric Acid B on T lymphocytes in vitroPhytotherapy Research, 2012
- Targeting apoptotic and autophagic pathways for cancer therapeuticsCancer Letters, 2011
- Selective inhibition of human leukemia cell growth and induction of cell cycle arrest and apoptosis by pseudolaric acid BJournal of Cancer Research and Clinical Oncology, 2010
- LC3 and Autophagy2008
- Oxidative stress and apoptosis: Impact on cancer therapyJournal of Pharmaceutical Sciences, 2007
- The signaling mechanism of ROS in tumor progressionCancer and Metastasis Reviews, 2006